Co-Diagnostics, Inc. (CODX) Insider Trading Activity
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $57M |
CODX Insider Trading Activity
CODX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
About Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Insider Activity of Co-Diagnostics, Inc.
Over the last 12 months, insiders at Co-Diagnostics, Inc. have bought $0 and sold $0 worth of Co-Diagnostics, Inc. stock.
On average, over the past 5 years, insiders at Co-Diagnostics, Inc. have bought $5,697 and sold $5.12M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,000 shares for transaction amount of $5,697 was made by Brown Brian Lee (Chief Financial Officer) on 2023‑03‑20.
List of Insider Buy and Sell Transactions, Co-Diagnostics, Inc.
| 2023-03-20 | Brown Brian Lee | Chief Financial Officer | 3,000 0.0095% | $1.90 | $5,697 | -35.79% | ||
| 2021-09-08 | Sale | Durenard Eugene | director | 2,000 0.007% | $10.46 | $20,910 | -37.92% | |
| 2021-05-19 | Sale | BENSON REED L | General Counsel | 108,334 0.3747% | $8.53 | $923,628 | -1.52% | |
| 2021-01-15 | Sale | Egan Dwight H | Chief Executive Officer | 38,046 0.1385% | $11.00 | $418,506 | -13.05% | |
| 2021-01-14 | Sale | SERBIN RICHARD S | director | 10,000 0.0353% | $10.29 | $102,900 | -9.74% | |
| 2021-01-13 | Sale | Durenard Eugene | director | 21,000 0.0734% | $10.09 | $211,890 | -8.44% | |
| 2021-01-13 | Sale | NELSON JAMES B | director | 25,000 0.0877% | $10.13 | $253,262 | -8.44% | |
| 2020-12-14 | Sale | SERBIN RICHARD S | director | 34,000 0.1206% | $10.10 | $343,400 | -11.77% | |
| 2020-12-10 | Sale | Durenard Eugene | director | 20,000 0.0726% | $10.15 | $203,000 | -9.03% | |
| 2020-11-25 | Sale | BENSON REED L | CFO and Secretary | 179,048 0.5796% | $10.50 | $1.88M | -20.35% | |
| 2020-11-24 | Sale | Egan Dwight H | Chief Executive Officer | 89,528 0.3335% | $10.51 | $940,939 | -8.38% | |
| 2020-11-23 | Sale | Egan Dwight H | Chief Executive Officer | 143,138 0.5331% | $10.44 | $1.49M | -7.67% | |
| 2020-11-20 | Sale | Egan Dwight H | Chief Executive Officer | 36,034 0.1349% | $11.09 | $399,617 | -12.53% | |
| 2020-05-28 | Sale | SERBIN RICHARD S | director | 42,500 0.159% | $18.02 | $766,050 | -23.13% | |
| 2020-05-26 | Sale | Durenard Eugene | director | 25,000 0.0917% | $18.24 | $456,000 | -25.35% | |
| 2020-05-20 | Sale | Durenard Eugene | director | 50,000 0.1769% | $18.14 | $906,750 | -26.83% | |
| 2020-05-19 | Sale | SERBIN RICHARD S | director | 50,000 0.1779% | $18.50 | $925,000 | -27.85% | |
| 2018-05-11 | Satterfield Brent | Chief Science Officer | 2,610 0.0209% | $1.82 | $4,750 | +21.47% | ||
| 2018-05-03 | Satterfield Brent | Chief Science Officer | 1,000 0.0081% | $1.91 | $1,910 | +16.75% | ||
| 2018-04-23 | Satterfield Brent | Chief Science Officer | 1,000 0.0083% | $2.02 | $2,020 | +12.63% |
Insider Historical Profitability
| Satterfield Brent | Chief Science Officer | 2275000 6.7482% | $824,232.50 | 5 | 0 | |
| Brown Brian Lee | Chief Financial Officer | 76236 0.2261% | $27,620.30 | 1 | 0 | <0.0001% |
| SERBIN RICHARD S | director | 2500 0.0074% | $905.75 | 0 | 4 | |
| BENSON REED L | General Counsel | 0 0% | $0 | 0 | 2 | |
| NELSON JAMES B | director | 0 0% | $0 | 0 | 1 | |
| Egan Dwight H | Chief Executive Officer | 0 0% | $0 | 0 | 4 | |
| Durenard Eugene | director | 0 0% | $0 | 0 | 5 |
CODX Institutional Investors: Active Positions
| Increased Positions | 14 | +29.79% | 256,134 | +4.55% |
| Decreased Positions | 16 | -34.04% | 103,192 | -1.83% |
| New Positions | 6 | New | 118,765 | New |
| Sold Out Positions | 6 | Sold Out | 41,854 | Sold Out |
| Total Postitions | 45 | -4.26% | 6M | +2.72% |
CODX Ownership Change vs Market
Institutional Investor Ownership
| Vanguard Group Inc | $654.00 | 5.23% | 1.78M | -3,101 | -0.17% | 2024-12-31 |
| Private Advisory Group Llc | $435.00 | 3.48% | 1.18M | +1M | New | 2024-12-31 |
| Renaissance Technologies Llc | $204.00 | 1.63% | 555,622 | -12,100 | -2.13% | 2024-12-31 |
| Blackrock, Inc. | $185.00 | 1.48% | 502,794 | -1,443 | -0.29% | 2025-03-31 |
| Geode Capital Management, Llc | $127.00 | 1.02% | 345,511 | +24,236 | +7.54% | 2024-12-31 |
| Bridgeway Capital Management, Llc | $100.00 | 0.8% | 272,900 | 0 | 0% | 2024-12-31 |
| Susquehanna International Group, Llp | $95.00 | 0.76% | 259,125 | +71,556 | +38.15% | 2024-12-31 |
| Bank Of New York Mellon Corp | $50.00 | 0.4% | 137,068 | 0 | 0% | 2025-03-31 |
| Kestra Advisory Services, Llc | $45.00 | 0.36% | 122,806 | -5,135 | -4.01% | 2024-12-31 |
| State Street Corp | $37.00 | 0.3% | 100,647 | 0 | 0% | 2024-12-31 |